SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-036369
Filing Date
2021-02-10
Accepted
2021-02-10 16:40:57
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 d98693d424b5.htm 424B5 391403
2 GRAPHIC g98693g13v36.jpg GRAPHIC 142502
3 GRAPHIC g98693g28s87.jpg GRAPHIC 62037
4 GRAPHIC g98693g65a65.jpg GRAPHIC 28862
5 GRAPHIC g98693g82u83.jpg GRAPHIC 178726
  Complete submission text file 0001193125-21-036369.txt   956864
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-227182 | Film No.: 21614531
SIC: 2834 Pharmaceutical Preparations